Mosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell Lymphoma (clinicaltrials.gov) - Oct 14, 2026 - P1 | N=9 | Active, not recruiting | Sponsor: Washington University School of Medicine | Trial completion date: Aug 2028 ➔ Apr 2028 | Trial primary completion date: Jan 2027 ➔ Sep 2026
Trial completion date • Trial primary completion date • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Follicular Lymphoma • Hematological Malignancies • High-grade B-cell lymphoma • Indolent Lymphoma • Lymphoma • Non-Hodgkin's Lymphoma • Oncology • Transplantation • CD20
|